首页|术后131I治疗对甲状腺乳头状癌患者血清P-Cadherin、CK-19和MMP-9影响的实验研究

术后131I治疗对甲状腺乳头状癌患者血清P-Cadherin、CK-19和MMP-9影响的实验研究

扫码查看
目的:探讨甲状腺乳头状癌患者血清P-钙粘蛋白(P-Cadherin)、细胞角蛋白-19(CK-19)和基质金属蛋白酶-9(MMP-9)的变化,以及甲状腺切除术后131I治疗对其的影响。方法:对50例甲状腺乳头状癌患者采用甲状腺全切术,术后1个月行131I核素治疗,1个月后测定患者治疗前后血清中P-Cadherin、CK-19和MMP-9水平。结果:甲状腺乳头状癌组血清P-Cadherin、CK-19和MMP-9水平较对照组显著升高(P<0.01),且甲状腺乳头状癌伴淋巴结转移患者比无伴淋巴结转移患者血P-Cadherin、CK-19和MMP-9水平显著升高(均P<0.01);甲状腺乳头状癌患者不伴淋巴结转移组和伴淋巴结转移组患者行甲状腺切除术后131I 治疗后血清P-Cadherin、CK-19和MMP-9的含量较治疗前均降低(均P>0.05);且伴淋巴结转移组治疗后血清P-Cadherin、CK-19和MMP-9的含量较不伴淋巴结转移组降低更显著(均P<0.01)。结论:血清P-Cadherin、CK-19和MMP-9可能与甲状腺乳头状癌发生发展有关,甲状腺切除术后131I 治疗能显著降低甲状腺乳头状癌患者P-Cadherin、CK-19和MMP-9水平,以期达到早期诊断早期防治的目的。
The effects of 131I treatment after thyroidectomy on the serum P-Cadherin、CK-19 and MMP-9 in patients with thyroid papilary carcinoma
Objective:To explore the change of131I treatment after thyroidectomy on thyroid papilary carcinoma patients and the impacts on the expressions of P-Cadherin、CK-19 and MMP-9. Methods: 50 cases of thyroid papilary carcinoma patients with thyroid ful cut method, then131 I nuclide therapy after1 months, the concentrations of P-Cadherin、CK-19 and MMP-9 in serum were detected before and after therapy.Results: The thyroid papilary carcinoma group serum P-Cadherin、CK-19 and MMP-9 levels were higher than the healthy control group(P<0.01); and he levels of serum P-Cadherin ,CK-19 and MMP-9 in papilary thyroid carcinoma with lymph node metastasis were significant higher than without lymph node metastasis(al P<0.01);The serum level of P-Cadherin ,CK-19 and MMP-9 on thyroid papilary carcinoma patients with lymph node metastasis and without lymph node metastasis after treatment were lower than those before treatment(P<0.01), moreover, the serum level of P-Cadherin ,CK-19 and MMP-9 on lymph node metastasis group after treatment were more lower than those on without lymph node metastasis group (P<0.05).Conclusion:There may be a relevant between serum P-Cadherin ,CK-19,MMP-9 and the incidence of thyroid papilary carcinoma.131I treatment after thyroidectomy can significantly reduce the levels of P-Cadherin ,CK-19 and MMP-9 in thyroid papilary carcinoma patients, which may in order to achieve the purpose of early diagnosis and early prevention.

Papilary Thyroid CarcinomaP-CadherinCK-19MMP-9

杜映军、冷立军

展开 >

湖南省益阳市第一中医院 湖南益阳 413002

甲状腺乳头状癌 P-钙粘蛋白 细胞角蛋白-19 基质金属蛋白酶-9

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(20)
  • 8